Supplementary Figure 4 from Selective Activity of the Histone Deacetylase Inhibitor AR-42 against Leukemia Stem Cells: A Novel Potential Strategy in Acute Myelogenous Leukemia
Year: 2023
Type: supplementary-materials
Abstract: PDF - 107K, AR-42, unlike PTL, does not upregulate HMOX-1 as a consequence of ROS induction.
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
OpenAlex ID: W4362493909
